vs

Side-by-side financial comparison of Arcosa, Inc. (ACA) and Genius Sports Ltd (GENI). Click either name above to swap in a different company.

Arcosa, Inc. is the larger business by last-quarter revenue ($716.7M vs $510.9M, roughly 1.4× Genius Sports Ltd). Arcosa, Inc. runs the higher net margin — 7.3% vs -12.3%, a 19.6% gap on every dollar of revenue. Genius Sports Ltd produced more free cash flow last quarter ($69.6M vs $55.8M). Over the past eight quarters, Genius Sports Ltd's revenue compounded faster (129.2% CAGR vs 9.4%).

Arcosa, Inc. is a provider of infrastructure-related products and solutions operating across three core segments: construction, energy, and transportation. It offers products including utility structures, construction aggregates, and transportation components, primarily serving customers across the North American market to support critical infrastructure development projects.

Genius Sports is a sports data and technology company that provides data management, video streaming and integrity services to sports leagues, bookmakers and media companies.

ACA vs GENI — Head-to-Head

Bigger by revenue
ACA
ACA
1.4× larger
ACA
$716.7M
$510.9M
GENI
Higher net margin
ACA
ACA
19.6% more per $
ACA
7.3%
-12.3%
GENI
More free cash flow
GENI
GENI
$13.8M more FCF
GENI
$69.6M
$55.8M
ACA
Faster 2-yr revenue CAGR
GENI
GENI
Annualised
GENI
129.2%
9.4%
ACA

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ACA
ACA
GENI
GENI
Revenue
$716.7M
$510.9M
Net Profit
$52.1M
$-63.0M
Gross Margin
22.9%
25.2%
Operating Margin
11.0%
-11.5%
Net Margin
7.3%
-12.3%
Revenue YoY
7.6%
Net Profit YoY
776.6%
EPS (diluted)
$1.06

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ACA
ACA
GENI
GENI
Q4 25
$716.7M
$510.9M
Q3 25
$797.8M
$335.4M
Q2 25
$736.9M
$215.2M
Q1 25
$632.0M
$119.7M
Q4 24
$666.2M
$413.0M
Q3 24
$640.4M
$285.8M
Q2 24
$664.7M
$184.1M
Q1 24
$598.6M
$97.2M
Net Profit
ACA
ACA
GENI
GENI
Q4 25
$52.1M
$-63.0M
Q3 25
$73.0M
Q2 25
$59.7M
$-47.3M
Q1 25
$23.6M
$-25.5M
Q4 24
$-7.7M
$-85.5M
Q3 24
$16.6M
$-47.1M
Q2 24
$45.6M
$-35.5M
Q1 24
$39.2M
$-25.2M
Gross Margin
ACA
ACA
GENI
GENI
Q4 25
22.9%
25.2%
Q3 25
24.1%
24.2%
Q2 25
22.5%
19.1%
Q1 25
19.8%
10.7%
Q4 24
19.3%
16.7%
Q3 24
21.3%
20.5%
Q2 24
20.8%
18.6%
Q1 24
18.6%
9.8%
Operating Margin
ACA
ACA
GENI
GENI
Q4 25
11.0%
-11.5%
Q3 25
14.1%
-15.3%
Q2 25
12.9%
-21.0%
Q1 25
8.8%
-20.3%
Q4 24
6.5%
-18.0%
Q3 24
5.3%
-13.9%
Q2 24
10.1%
-16.8%
Q1 24
8.9%
-23.7%
Net Margin
ACA
ACA
GENI
GENI
Q4 25
7.3%
-12.3%
Q3 25
9.2%
Q2 25
8.1%
-22.0%
Q1 25
3.7%
-21.3%
Q4 24
-1.2%
-20.7%
Q3 24
2.6%
-16.5%
Q2 24
6.9%
-19.3%
Q1 24
6.5%
-25.9%
EPS (diluted)
ACA
ACA
GENI
GENI
Q4 25
$1.06
Q3 25
$1.48
Q2 25
$1.22
Q1 25
$0.48
Q4 24
$-0.16
Q3 24
$0.34
Q2 24
$0.93
Q1 24
$0.80

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ACA
ACA
GENI
GENI
Cash + ST InvestmentsLiquidity on hand
$214.6M
$280.6M
Total DebtLower is stronger
$1.5B
Stockholders' EquityBook value
$2.6B
$724.5M
Total Assets
$5.0B
$1.1B
Debt / EquityLower = less leverage
0.57×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ACA
ACA
GENI
GENI
Q4 25
$214.6M
$280.6M
Q3 25
$220.0M
$110.2M
Q2 25
$189.7M
$110.2M
Q1 25
$167.9M
$110.2M
Q4 24
$187.3M
$100.3M
Q3 24
$756.8M
$100.3M
Q2 24
$103.7M
$100.3M
Q1 24
$176.5M
$100.3M
Total Debt
ACA
ACA
GENI
GENI
Q4 25
$1.5B
Q3 25
$1.6B
Q2 25
$1.7B
Q1 25
$1.7B
Q4 24
$1.7B
Q3 24
$1.2B
Q2 24
$699.9M
Q1 24
$600.6M
Stockholders' Equity
ACA
ACA
GENI
GENI
Q4 25
$2.6B
$724.5M
Q3 25
$2.6B
$572.4M
Q2 25
$2.5B
$572.4M
Q1 25
$2.5B
$572.4M
Q4 24
$2.4B
$573.0M
Q3 24
$2.4B
$573.0M
Q2 24
$2.4B
$573.0M
Q1 24
$2.4B
$573.0M
Total Assets
ACA
ACA
GENI
GENI
Q4 25
$5.0B
$1.1B
Q3 25
$5.1B
$792.3M
Q2 25
$5.0B
$792.3M
Q1 25
$4.9B
$792.3M
Q4 24
$4.9B
$775.7M
Q3 24
$4.4B
$775.7M
Q2 24
$3.8B
$775.7M
Q1 24
$3.7B
$775.7M
Debt / Equity
ACA
ACA
GENI
GENI
Q4 25
0.57×
Q3 25
0.61×
Q2 25
0.67×
Q1 25
0.68×
Q4 24
0.69×
Q3 24
0.51×
Q2 24
0.29×
Q1 24
0.25×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ACA
ACA
GENI
GENI
Operating Cash FlowLast quarter
$120.0M
$81.9M
Free Cash FlowOCF − Capex
$55.8M
$69.6M
FCF MarginFCF / Revenue
7.8%
13.6%
Capex IntensityCapex / Revenue
9.0%
2.4%
Cash ConversionOCF / Net Profit
2.30×
TTM Free Cash FlowTrailing 4 quarters
$175.5M
$33.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ACA
ACA
GENI
GENI
Q4 25
$120.0M
$81.9M
Q3 25
$160.6M
$-4.8M
Q2 25
$61.2M
$-1.2M
Q1 25
$-700.0K
$-14.6M
Q4 24
$248.2M
$14.9M
Q3 24
$135.0M
$-9.2M
Q2 24
$38.3M
Q1 24
$80.5M
Free Cash Flow
ACA
ACA
GENI
GENI
Q4 25
$55.8M
$69.6M
Q3 25
$121.0M
$-14.2M
Q2 25
$33.4M
$-5.8M
Q1 25
$-34.7M
$-16.0M
Q4 24
$194.9M
$11.3M
Q3 24
$100.6M
$-11.6M
Q2 24
$-9.3M
Q1 24
$26.1M
FCF Margin
ACA
ACA
GENI
GENI
Q4 25
7.8%
13.6%
Q3 25
15.2%
-4.2%
Q2 25
4.5%
-2.7%
Q1 25
-5.5%
-13.4%
Q4 24
29.3%
2.7%
Q3 24
15.7%
-4.1%
Q2 24
-1.4%
Q1 24
4.4%
Capex Intensity
ACA
ACA
GENI
GENI
Q4 25
9.0%
2.4%
Q3 25
5.0%
2.8%
Q2 25
3.8%
2.1%
Q1 25
5.4%
1.2%
Q4 24
8.0%
0.9%
Q3 24
5.4%
0.9%
Q2 24
7.2%
Q1 24
9.1%
Cash Conversion
ACA
ACA
GENI
GENI
Q4 25
2.30×
Q3 25
2.20×
Q2 25
1.03×
Q1 25
-0.03×
Q4 24
Q3 24
8.13×
Q2 24
0.84×
Q1 24
2.05×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ACA
ACA

Engineered Structures$301.1M42%
Total Construction Materials$276.8M39%
Specialty Materials And Asphalt$110.2M15%
Construction Site Support$28.6M4%

GENI
GENI

Segment breakdown not available.

Related Comparisons